Jushi Holdings JUSHF
OTC JUSHF
$0.42 +0.01 (+2.44%)
At close: Aug 7, 2026 · 4:00 PM EDT

Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026)

Jushi Holdings (JUSHF) posted quarterly Cash from Investing Activities of -$3.9 million for Q2 2026, down 749.02% year-over-year from $600444.1 in Q2 2025, and up 4.49% quarter-over-quarter from -$4.1 million in Q1 2026.

Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has reported Cash from Investing Activities for 6 consecutive years, with -$3.9 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 749.02% year-over-year to -$3.9 million; the TTM figure through Jun 2026 stood at -$16.4 million (down 27.26% YoY), while the FY2025 annual figure was -$13.2 million, down 87.09% from the prior year.
  • Cash from Investing Activities improved to -$3.9 million in Q2 2026 per JUSHF's latest filing, from -$4.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1.7 million in Q2 2024 and bottomed at -$38.1 million in Q2 2022.
  • Historically, Cash from Investing Activities has averaged -$6.4 million across 5 years, with a median of -$4.0 million in 2026.
  • On a YoY basis, Cash from Investing Activities climbed as much as 348.1% in 2024 and fell as far as 2112.2% in 2024.
  • Jushi Holdings' Cash from Investing Activities stood at -$7.7 million in 2022, then surged by 95.76% to -$328000.0 in 2023, then plunged by 2112.2% to -$7.3 million in 2024, then soared by 57.69% to -$3.1 million in 2025, then decreased by 26.94% to -$3.9 million in 2026.
  • Business Quant data shows JUSHF's Cash from Investing Activities at -$3.9 million in Q2 2026, -$4.1 million in Q1 2026, and -$3.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Jushi Holdings 83.87 Mn 50.54 Mn 31.53 Mn -3.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.90 Mn
Jun 30, 2026 -3.90 Mn
Mar 31, 2026 -4.08 Mn
Mar 31, 2026 -4.08 Mn
Dec 31, 2025 -3.07 Mn
Dec 31, 2025 -3.07 Mn
Sep 30, 2025 -5.32 Mn
Sep 30, 2025 -5.32 Mn
Jun 30, 2025 -459,000.00
Jun 30, 2025 -459,000.00
Mar 31, 2025 -4.38 Mn
Mar 31, 2025 -4.38 Mn
Dec 31, 2024 -7.26 Mn
Dec 31, 2024 -7.26 Mn
Sep 30, 2024 -770,000.00
Sep 30, 2024 -770,000.00
Jun 30, 2024 1.70 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 -743,000.00
Mar 31, 2024 -743,000.00